These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36905562)

  • 1. Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy.
    Berteotti M; Gori AM; Giusti B; Fortini A; Grossi G; Ciardetti N; Migliorini A; Lotti E; Valenti R; Di Mario C; Marchionni N; Marcucci R
    J Thromb Thrombolysis; 2023 May; 55(4):667-679. PubMed ID: 36905562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention.
    Kitahara H; Yamashita D; Sato T; Suzuki S; Hiraga T; Yamazaki T; Matsumoto T; Kobayashi T; Ohno Y; Harada J; Fukushima K; Asano T; Ishio N; Uchiyama R; Miyahara H; Okino S; Sano M; Kuriyama N; Yamamoto M; Sakamoto N; Kanda J; Kobayashi Y
    J Cardiol; 2023 Sep; 82(3):207-214. PubMed ID: 37336423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation.
    Sammut MA; Conway D; Iqbal J; Krishnamurthy A; Morgan KP; Morris PD; Richardson JD; Rothman AMK; Gunn JP; Storey RF
    Expert Rev Cardiovasc Ther; 2024 Jul; 22(7):339-345. PubMed ID: 38949642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
    Kim IS; Jeong YH; Park Y; Yoon SE; Kwon TJ; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
    Br J Clin Pharmacol; 2012 Apr; 73(4):629-40. PubMed ID: 22007612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis Comparing Potent Oral P2Y
    Casula M; Fortuni F; Ferlini M; Fabris F; Oltrona Visconti L; Leonardi S
    Am J Cardiovasc Drugs; 2021 Mar; 21(2):231-240. PubMed ID: 32895853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance.
    Siasos G; Oikonomou E; Vavuranakis M; Kokkou E; Mourouzis K; Tsalamandris S; Zaromitidou M; Kioufis S; Tsigkou V; Deftereos S; Stefanadis C; Tousoulis D
    Cardiology; 2017; 137(2):104-113. PubMed ID: 28329746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI.
    Costa F; Valgimigli M; Steg PG; Bhatt DL; Hohnloser SH; Ten Berg JM; Miede C; Nordaby M; Lip GYH; Oldgren J; Cannon CP
    Eur Heart J Cardiovasc Pharmacother; 2022 May; 8(3):216-226. PubMed ID: 33258897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study.
    Bor WL; de Veer AJW; Olie RH; Rikken SAOF; Chan Pin Yin DRPP; Herrman JPR; Vrolix M; Meuwissen M; Vandendriessche T; van Mieghem C; Magro M; Bennaghmouch N; Hermanides R; Adriaenssens T; Dewilde WJM; Ten Berg JM
    EuroIntervention; 2022 Jul; 18(4):e303-e313. PubMed ID: 35370126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany.
    Zeymer U; Toelg R; Wienbergen H; Hobbach HP; Cuneo A; Bekeredjian R; Ritter O; Hailer B; Hertting K; Hennersdorf M; Scholtz W; Lanzer P; Mudra H; Schwefer M; Schwimmbeck PL; Liebetrau C; Thiele H; Claas C; Riemer T; Zahn R
    Herz; 2023 Mar; 48(2):134-140. PubMed ID: 35243515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials.
    Andò G; Costa F
    Int J Cardiol; 2020 Mar; 302():95-102. PubMed ID: 31924397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry.
    Rubboli A; Schlitt A; Kiviniemi T; Biancari F; Karjalainen PP; Valencia J; Laine M; Kirchhof P; Niemelä M; Vikman S; Lip GY; Airaksinen KE;
    Clin Cardiol; 2014 Jun; 37(6):357-64. PubMed ID: 24481953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Fanaroff AC; Lopes RD
    Prog Cardiovasc Dis; 2021; 69():11-17. PubMed ID: 34883097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II program.
    Chow JK; Bagai A; Tan MK; Har BJ; Yip AMC; Paniagua M; Elbarouni B; Bainey KR; Paradis JM; Maranda R; Cantor WJ; Eisenberg MJ; Dery JP; Madan M; Cieza T; Matteau A; Roth S; Lavi S; Glanz A; Gao D; Tahiliani R; Welsh RC; Kim HH; Robinson SD; Daneault B; Chong AY; Le May MR; Ahooja V; Gregoire JC; Nadeau PL; Laksman Z; Heilbron B; Yung D; Minhas K; Bourgeois R; Overgaard CB; Bonakdar H; Logsetty G; Lavoie AJ; De LaRochelliere R; Mansour S; Spindler C; Yan AT; Goodman SG;
    J Cardiol; 2023 Aug; 82(2):153-161. PubMed ID: 36931433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention.
    Lianos I; Varlamos C; Benetou DR; Mantis C; Kintis K; Dragona VM; Kanakakis I; Sionis D; Patsilinakos S; Alexopoulos D
    J Thromb Thrombolysis; 2023 Jan; 55(1):42-50. PubMed ID: 36369420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention.
    Mihajlovic M; Marinkovic M; Kozieł M; Mujovic N; Lip GYH; Potpara TS
    Kardiol Pol; 2020 Jun; 78(6):512-519. PubMed ID: 32543800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation.
    Baturina O; Andreev D; Fedina L; Mirzaev K; Ivashchenko D; Ryzhikova K; Grishina E; Bochkov P; Shevchenko R; Sychev D
    Pharmacology; 2022; 107(3-4):216-226. PubMed ID: 35073541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.
    Nakamura M; Kadota K; Takahashi A; Kanda J; Anzai H; Ishii Y; Shibata Y; Yasaka Y; Takamisawa I; Yamaguchi J; Takeda Y; Harada A; Motohashi T; Iijima R; Uemura S; Murakami Y;
    J Am Heart Assoc; 2020 May; 9(10):e015439. PubMed ID: 32394794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials).
    Eccleston DS; Kim JM; Ten Berg JM; Steg PG; Bhatt DL; Hohnloser SH; de Veer A; Nordaby M; Miede C; Kimura T; Lip GYH; Oldgren J; Cannon CP
    Clin Cardiol; 2021 Jul; 44(7):1002-1010. PubMed ID: 34042199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.